<!DOCTYPE html>
<html lang="en" data-arca>
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Psoriatic Arthritis BRA â€” ArcaScience | Biologic & JAK Inhibitor Benefit-Risk Analysis</title>
  <meta name="description" content="AI-driven benefit-risk analysis for Psoriatic Arthritis therapies. Comprehensive BRA for IL-17 inhibitors, IL-23 blockers, JAK inhibitors, TNF inhibitors, and PDE4 inhibitors across joint, skin, enthesitis, dactylitis, nail, and spine domains.">

  <link rel="preload" href="/fonts/Inter-Variable.woff2" as="font" type="font/woff2" crossorigin>
  <link rel="preload" href="/fonts/Literata-Variable.woff2" as="font" type="font/woff2" crossorigin>
  <link rel="stylesheet" href="/dist/arcascience-global.min.css">

  <script>
    (function(){
      if(window.matchMedia&&window.matchMedia('(prefers-reduced-motion: reduce)').matches){
        document.documentElement.classList.add('reduced-motion');
      }
    })();
  </script>
</head>
<body>

  <div data-scroll-progress></div>

  <!-- NAVIGATION (identical to ta-oncology.html) -->
  <nav class="arca-nav" data-nav="sticky" role="navigation" aria-label="Main navigation">
    <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px; display: flex; align-items: center; justify-content: space-between; height: 100%;">
      <a href="/" aria-label="ArcaScience home"><img src="/images/arcascience-logo.svg" alt="ArcaScience" height="32"></a>
      <div style="display: flex; align-items: center; gap: 32px;">
        <a href="/" class="arca-nav-link">Home</a>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/platform-overview" class="arca-nav-link">Platform <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 260px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/platform-overview" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Platform Overview</a>
            <a href="/platform-how-it-works" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">How It Works</a>
            <a href="/platform-data-intelligence" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Data Intelligence</a>
            <a href="/platform-ai-models" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">AI Models</a>
            <a href="/platform-outputs" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Regulatory Outputs</a>
            <a href="/platform-integrations" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Integrations</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <a href="/security-compliance" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Security &amp; Compliance</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/solution-therapeutic-area" class="arca-nav-link is-active">Solutions <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 260px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">By Approach</p>
            <a href="/solution-therapeutic-area" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Therapeutic Area</a>
            <a href="/solution-lifecycle-phase" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Lifecycle Phase</a>
            <a href="/solution-role" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Role</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">By Stage</p>
            <a href="/solution-early-development" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Early Development</a>
            <a href="/solution-late-development" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Late Development</a>
            <a href="/solution-post-marketing" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Post-Marketing</a>
            <a href="/solution-market-access" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Market Access</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">Therapeutic Areas</p>
            <a href="/ta-oncology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Oncology</a>
            <a href="/disease-breast-cancer" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Breast Cancer</a>
            <a href="/disease-melanoma" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Melanoma</a>
            <a href="/disease-nsclc" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">NSCLC</a>
            <a href="/disease-aml" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">AML</a>
            <a href="/ta-neurology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Neurology</a>
            <a href="/disease-alzheimers" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Alzheimer's</a>
            <a href="/disease-parkinsons" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Parkinson's</a>
            <a href="/disease-multiple-sclerosis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Multiple Sclerosis</a>
            <a href="/disease-sma" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">SMA</a>
            <a href="/ta-immunology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Immunology</a>
            <a href="/disease-rheumatoid-arthritis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Rheumatoid Arthritis</a>
            <a href="/disease-psoriasis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Psoriasis</a>
            <a href="/disease-lupus" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Lupus</a>
            <a href="/ta-cardiology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Cardiology</a>
            <a href="/disease-afib" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">AFib</a>
            <a href="/disease-heart-failure" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Heart Failure</a>
            <a href="/ta-respiratory" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Respiratory</a>
            <a href="/disease-asthma" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Asthma</a>
            <a href="/disease-cystic-fibrosis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Cystic Fibrosis</a>
            <a href="/ta-rare-diseases" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Rare Diseases</a>
            <a href="/disease-sma" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">SMA</a>
            <a href="/disease-cystic-fibrosis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Cystic Fibrosis</a>
            <a href="/ta-dermatology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Dermatology</a>
            <a href="/disease-atopic-dermatitis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Atopic Dermatitis</a>
            <a href="/disease-psoriatic-arthritis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Psoriatic Arthritis</a>
            <a href="/ta-hematology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Hematology</a>
            <a href="/disease-multiple-myeloma" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Multiple Myeloma</a>
            <a href="/disease-cll" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">CLL</a>
            <a href="/disease-sickle-cell" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Sickle Cell Disease</a>
            <a href="/ta-gastroenterology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Gastroenterology</a>
            <a href="/disease-crohns-disease" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Crohn's Disease</a>
            <a href="/disease-ulcerative-colitis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Ulcerative Colitis</a>
            <a href="/ta-endocrinology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Endocrinology</a>
            <a href="/disease-type-2-diabetes" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Type 2 Diabetes</a>
            <a href="/disease-obesity" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Obesity</a>
            <a href="/ta-infectious-disease" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Infectious Disease</a>
            <a href="/disease-hiv" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">HIV</a>
            <a href="/disease-hepatitis-b" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Hepatitis B</a>
            <a href="/ta-pediatrics" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Pediatrics</a>
            <a href="/disease-pediatric-epilepsy" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Pediatric Epilepsy</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/evidence-case-studies-hub" class="arca-nav-link">Evidence <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 220px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/evidence-case-studies-hub" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">Case Studies</a>
            <a href="/evidence-publications" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">Publications</a>
            <a href="/evidence-metrics" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">Platform Metrics</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/about" class="arca-nav-link">Company <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 200px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/about" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">About ArcaScience</a>
            <a href="/leadership" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">Leadership</a>
            <a href="/careers" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">Careers</a>
            <a href="/science-methodology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">Science &amp; Methodology</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/resources" class="arca-nav-link">Resources <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; right: -12px; min-width: 220px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/resources" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">Resource Hub</a>
            <a href="/resources-whitepapers" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">Whitepapers</a>
            <a href="/resources-webinars" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">Webinars &amp; Events</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <a href="/resources-faq" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">FAQ</a>
            <a href="/resources-glossary" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px;">Glossary</a>
          </div>
        </div>
      </div>
      <a href="/contact" class="arca-btn-primary" style="height: 40px; padding: 8px 24px; font-size: 0.875rem;">Talk to a Scientist</a>
    </div>
  </nav>

  <div style="height: var(--nav-height);"></div>

  <main role="main">

    <!-- HERO -->
    <section class="arca-bg-blue-900" style="position: relative; overflow: hidden; padding: var(--space-8) 0 var(--space-9);" data-animate>
      <div style="position: absolute; top: -100px; right: -100px; width: 500px; height: 500px; background: radial-gradient(circle, rgba(13, 124, 107, 0.12) 0%, transparent 70%); border-radius: 50%; filter: blur(60px); pointer-events: none; animation: as-float 8s ease-in-out infinite; z-index: 0;"></div>
      <div style="position: absolute; bottom: -80px; left: -80px; width: 400px; height: 400px; background: radial-gradient(circle, rgba(59, 125, 216, 0.06) 0%, transparent 70%); border-radius: 50%; filter: blur(60px); pointer-events: none; animation: as-float 10s ease-in-out infinite reverse; z-index: 0;"></div>

      <svg width="420" height="320" viewBox="0 0 420 320" fill="none" aria-hidden="true" style="position: absolute; right: -20px; top: 50%; transform: translateY(-50%); opacity: 0.12; pointer-events: none; z-index: 0;">
        <circle cx="210" cy="160" r="16" stroke="rgba(13,124,107,0.5)" stroke-width="1.5" fill="none"/>
        <circle cx="210" cy="160" r="6" fill="rgba(13,124,107,0.3)"/>
        <circle cx="290" cy="100" r="10" stroke="rgba(13,124,107,0.4)" stroke-width="1" fill="none"/>
        <circle cx="130" cy="100" r="10" stroke="rgba(13,124,107,0.4)" stroke-width="1" fill="none"/>
        <circle cx="290" cy="220" r="10" stroke="rgba(13,124,107,0.4)" stroke-width="1" fill="none"/>
        <circle cx="130" cy="220" r="10" stroke="rgba(13,124,107,0.4)" stroke-width="1" fill="none"/>
        <line x1="210" y1="160" x2="290" y2="100" stroke="rgba(13,124,107,0.3)" stroke-width="1.5"/>
        <line x1="210" y1="160" x2="130" y2="100" stroke="rgba(13,124,107,0.3)" stroke-width="1.5"/>
        <line x1="210" y1="160" x2="290" y2="220" stroke="rgba(13,124,107,0.3)" stroke-width="1.5"/>
        <line x1="210" y1="160" x2="130" y2="220" stroke="rgba(13,124,107,0.3)" stroke-width="1.5"/>
      </svg>

      <div style="position: relative; z-index: 1; max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <nav aria-label="Breadcrumb" style="margin-bottom: var(--space-5);">
          <ol style="list-style: none; padding: 0; margin: 0; display: flex; align-items: center; gap: 8px; font-size: 0.75rem;">
            <li><a href="/" style="color: rgba(255,255,255,0.65); text-decoration: none;">Home</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li><a href="/solution-therapeutic-area" style="color: rgba(255,255,255,0.65); text-decoration: none;">Therapeutic Areas</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li><a href="/ta-dermatology" style="color: rgba(255,255,255,0.65); text-decoration: none;">Dermatology</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li style="color: var(--white);">Psoriatic Arthritis</li>
          </ol>
        </nav>

        <div style="max-width: 820px;">
          <p data-animate="fade" class="arca-label arca-text-blue-400" style="margin-bottom: var(--space-3);">Dermatology &rsaquo; Psoriatic Arthritis</p>
          <h1 data-animate="slide-up" data-animate-delay="100" class="arca-display-lg arca-text-white" style="margin-bottom: var(--space-5);">
            Biologic &amp; JAK Inhibitor Benefit-Risk Analysis for Psoriatic Arthritis
          </h1>
          <p data-animate="slide-up" data-animate-delay="200" class="arca-body-lg" style="color: rgba(255,255,255,0.85); max-width: 680px; margin-bottom: var(--space-7);">
            Psoriatic arthritis demands multi-domain BRA across six distinct mechanism classes: IL-17 inhibitors (secukinumab, ixekizumab, bimekizumab), IL-23 blockers (guselkumab), JAK inhibitors (tofacitinib, upadacitinib, deucravacitinib/TYK2), TNF inhibitors, PDE4 inhibitors (apremilast), and emerging dual-pathway agents. ArcaScience delivers integrated benefit-risk analysis spanning joint, skin, enthesitis, dactylitis, nail, and axial domains.
          </p>
          <div data-animate="slide-up" data-animate-delay="300" style="display: flex; gap: 16px; flex-wrap: wrap;">
            <a href="/platform-overview" class="arca-btn-primary-inverted">See Platform</a>
            <a href="/contact?disease=psoriatic-arthritis" class="arca-btn-secondary" style="border-color: rgba(255,255,255,0.3); color: var(--white);">Request Demo</a>
          </div>
        </div>
      </div>
    </section>

    <!-- KEY STATISTICS -->
    <section class="arca-credibility-bar" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="display: grid; grid-template-columns: repeat(4, 1fr); gap: 32px; text-align: center;">
          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="1000000" data-countup-suffix="+">1,000,000+</span>
            <p class="arca-caption">PsA patients in the US</p>
          </div>
          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="2100" data-countup-suffix="+">2,100+</span>
            <p class="arca-caption">PsA clinical trials analyzed</p>
          </div>
          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="6">6</span>
            <p class="arca-caption">Mechanism classes approved for PsA</p>
          </div>
          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="30" data-countup-suffix="%+">30%+</span>
            <p class="arca-caption">Of psoriasis patients develop PsA</p>
          </div>
        </div>
      </div>
    </section>

    <!-- DISEASE OVERVIEW -->
    <section style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="max-width: 720px; margin: 0 auto 48px; text-align: center;">
          <p class="arca-section-label">Disease Overview</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-5);">Why Psoriatic Arthritis Multi-Domain Therapy Demands Specialized BRA</h2>
          <p class="arca-body-lg arca-text-grey-600">
            Psoriatic arthritis involves simultaneous inflammation across joints, skin, entheses, digits, nails, and spine, requiring multi-endpoint efficacy assessment against diverse safety profiles spanning cardiovascular risk, opportunistic infections, and paradoxical inflammatory reactions across six approved mechanism classes.
          </p>
        </div>

        <div data-animate-stagger style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px;">
          <div class="arca-card" data-animate="slide-up">
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">JAK Inhibitor MACE/VTE Risk</h3>
            <p class="arca-body-sm arca-text-grey-600">
              The ORAL Surveillance study revealed increased cardiovascular (MACE) and thromboembolic (VTE) events with tofacitinib versus TNF inhibitors in RA, triggering FDA boxed warnings class-wide across all JAK inhibitors. Comparative safety profiling of tofacitinib, upadacitinib, and deucravacitinib (TYK2-selective) in PsA populations requires dedicated BRA models that account for differing JAK selectivity and population-specific cardiovascular risk factors.
            </p>
          </div>
          <div class="arca-card" data-animate="slide-up">
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">IL-17 Inhibitor Fungal Infections &amp; IBD</h3>
            <p class="arca-body-sm arca-text-grey-600">
              IL-17 blockade with secukinumab, ixekizumab, and bimekizumab carries elevated Candida infection rates due to IL-17's critical role in mucocutaneous immunity. Additionally, IL-17 inhibitors are associated with new-onset or exacerbation of inflammatory bowel disease (IBD) and paradoxical psoriasis flares. BRA must quantify these mechanism-specific risks against multi-domain efficacy advantages in PsA.
            </p>
          </div>
          <div class="arca-card" data-animate="slide-up">
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">Multi-Domain Efficacy-Safety Tradeoffs</h3>
            <p class="arca-body-sm arca-text-grey-600">
              PsA uniquely requires simultaneous assessment across joint (ACR), skin (PASI), enthesitis, dactylitis, nail, and axial spine domains. Not all mechanism classes perform equally across domains&mdash;IL-17 inhibitors excel in skin and enthesitis while JAK inhibitors offer broader multi-domain coverage. Treatment sequencing across mechanism classes after inadequate response demands integrated multi-endpoint BRA frameworks.
            </p>
          </div>
        </div>
      </div>
    </section>

    <!-- ARCASCIENCE APPROACH -->
    <div class="arca-section-divider" aria-hidden="true"></div>

    <section class="arca-bg-grey-50 arca-bg-rings" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-8);">
          <p class="arca-section-label">Platform Capabilities</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-4);">How ArcaScience Addresses Psoriatic Arthritis BRA</h2>
          <p class="arca-body-lg arca-text-grey-600" style="max-width: 680px; margin: 0 auto;">Our modules are configured with PsA multi-domain trial data, JAK inhibitor cardiovascular risk models, and regulatory templates for biologic and targeted synthetic DMARD submissions.</p>
        </div>

        <div data-animate-stagger style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px;">
          <div class="arca-card arca-card-colored-top is-data" data-animate="slide-up">
            <span class="arca-module-tag is-data">Data Intelligence</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">PsA Multi-Domain Trial Data</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">2,100+ PsA clinical trials including DISCOVER-1/2, SPIRIT-P1/P2, SELECT-PsA-1/2, BE OPTIMAL/COMPLETE, and OPAL Broaden/Beyond programs. Comprehensive psoriasis-PsA overlap databases linking dermatology and rheumatology registries, with multi-domain outcome tracking across ACR, PASI, enthesitis, dactylitis, nail, and axial endpoints.</p>
            <a href="/platform-data-intelligence" class="arca-btn-tertiary">Explore Data Engine <span class="arca-arrow">&rarr;</span></a>
          </div>
          <div class="arca-card arca-card-colored-top is-analytics" data-animate="slide-up">
            <span class="arca-module-tag is-analytics">Decision Intelligence</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">MACE &amp; Multi-Domain AI Models</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">AI-powered MACE risk stratification models comparing JAK inhibitors by selectivity profile, fungal infection prediction algorithms for IL-17 blockade, multi-domain response modeling across all six PsA disease manifestations, and treatment sequencing optimization to guide mechanism class selection after inadequate response.</p>
            <a href="/platform-ai-models" class="arca-btn-tertiary">Explore AI Models <span class="arca-arrow">&rarr;</span></a>
          </div>
          <div class="arca-card arca-card-colored-top is-output" data-animate="slide-up">
            <span class="arca-module-tag is-output">Automated Outputs</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">PsA Regulatory Outputs</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">PSURs with multi-domain safety sections covering joint, skin, and systemic adverse events. JAK inhibitor boxed warning compliance documents for FDA submissions. Biosimilar switching BRA for TNF inhibitor transitions. Comparative effectiveness reports across mechanism classes supporting HTA submissions and formulary positioning.</p>
            <a href="/platform-outputs" class="arca-btn-tertiary">Explore Outputs <span class="arca-arrow">&rarr;</span></a>
          </div>
        </div>
      </div>
    </section>

    <!-- KEY METRICS -->
    <section class="arca-bg-blue-50 arca-bg-mesh" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-8);">
          <p class="arca-section-label">Psoriatic Arthritis Intelligence</p>
          <h2 class="arca-display-sm">Platform Performance in Psoriatic Arthritis</h2>
        </div>
        <div style="display: grid; grid-template-columns: repeat(4, 1fr); gap: 32px; text-align: center;">
          <div>
            <span class="arca-stat-lg" style="color: var(--indigo-600);" data-countup="7800000000" data-countup-suffix="+">7,800,000,000+</span>
            <p class="arca-caption arca-text-grey-600">Rheumatology/dermatology data points</p>
          </div>
          <div>
            <span class="arca-stat-lg" style="color: var(--indigo-600);" data-countup="66" data-countup-suffix="%">66%</span>
            <p class="arca-caption arca-text-grey-600">Faster MACE signal detection</p>
          </div>
          <div>
            <span class="arca-stat-lg" style="color: var(--indigo-600);" data-countup="10">10</span>
            <p class="arca-caption arca-text-grey-600">PsA-specific AI models deployed</p>
          </div>
          <div>
            <span class="arca-stat-lg" style="color: var(--indigo-600);" data-countup="8">8</span>
            <p class="arca-caption arca-text-grey-600">PsA regulatory submissions supported</p>
          </div>
        </div>
      </div>
    </section>

    <!-- CASE EVIDENCE -->
    <section style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 64px; align-items: center;">
          <div>
            <p class="arca-section-label">Case Evidence &mdash; Psoriatic Arthritis</p>
            <h2 class="arca-heading-1" style="margin-bottom: var(--space-5);">JAK Inhibitor Cardiovascular Safety Profiling in PsA</h2>
            <div style="margin-bottom: var(--space-5);">
              <h3 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--indigo-600);">Challenge</h3>
              <p class="arca-body-sm arca-text-grey-600">A pharma company needed to differentiate MACE and VTE risk profiles between tofacitinib and upadacitinib in PsA populations versus RA populations, given the class-wide boxed warning triggered by ORAL Surveillance data generated in an RA cohort with higher baseline cardiovascular risk.</p>
            </div>
            <div style="margin-bottom: var(--space-5);">
              <h3 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--indigo-600);">Result</h3>
              <p class="arca-body-sm arca-text-grey-600">ArcaScience's AI models enabled population-specific MACE signal differentiation, demonstrating distinct cardiovascular risk trajectories in PsA vs. RA populations and providing evidence to support nuanced labeling discussions with FDA and EMA, with significantly improved VTE risk prediction accuracy.</p>
            </div>
            <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 24px; margin-bottom: var(--space-6);">
              <div>
                <span class="arca-stat-sm" style="color: var(--indigo-600);" data-countup="3.7" data-countup-suffix="x">3.7x</span>
                <p class="arca-caption arca-text-grey-600">Faster MACE signal differentiation</p>
              </div>
              <div>
                <span class="arca-stat-sm" style="color: var(--indigo-600);" data-countup="39" data-countup-suffix="%">39%</span>
                <p class="arca-caption arca-text-grey-600">Improvement in VTE risk prediction accuracy</p>
              </div>
            </div>
            <a href="/evidence-case-studies-hub" class="arca-btn-tertiary">View All Case Studies <span class="arca-arrow">&rarr;</span></a>
          </div>
          <div class="arca-testimonial" style="text-align: left;">
            <div class="arca-testimonial-quote" style="padding-left: 24px; border-left: 3px solid var(--blue-400);">
              The ability to differentiate MACE risk in our PsA population from the RA-derived ORAL Surveillance data was critical for our regulatory strategy. ArcaScience's models gave us the population-specific evidence we needed to have a more nuanced safety conversation with both FDA and EMA.
            </div>
            <div class="arca-testimonial-attribution" style="margin-top: var(--space-5);">
              <p class="arca-body-md" style="font-weight: 600;">Head of Immunology Safety</p>
              <p class="arca-body-sm arca-text-grey-600">Global Pharma Company</p>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- FAQ ACCORDION -->
    <div class="arca-section-divider" aria-hidden="true"></div>

    <section class="arca-bg-teal-100 arca-bg-rings" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="max-width: 720px; margin: 0 auto 48px; text-align: center;">
          <p class="arca-section-label">Frequently Asked Questions</p>
          <h2 class="arca-display-sm">Psoriatic Arthritis BRA</h2>
        </div>
        <div style="max-width: 820px; margin: 0 auto;">
          <div data-accordion="group">
            <div data-accordion-item style="border-bottom: 1px solid var(--grey-200);">
              <button data-accordion-trigger aria-expanded="false" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">How does ArcaScience assess JAK inhibitor MACE risk specific to PsA populations?</h3>
                <svg data-accordion-icon width="16" height="16" viewBox="0 0 16 16" fill="none" style="flex-shrink: 0;"><path d="M4 6l4 4 4-4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg>
              </button>
              <div data-accordion-content aria-hidden="true" style="max-height: 0; overflow: hidden; transition: max-height 300ms ease-out;">
                <div style="padding: 0 0 var(--space-5);">
                  <p class="arca-body-sm arca-text-grey-600">Our platform builds PsA-specific cardiovascular risk models that account for the distinct baseline risk profiles of PsA patients compared to the RA cohort studied in ORAL Surveillance. AI models stratify MACE and VTE risk by JAK selectivity (pan-JAK vs. JAK1-selective vs. TYK2-selective), patient age, cardiovascular comorbidities, and concomitant medications. This enables population-specific benefit-risk assessments rather than relying solely on class-wide extrapolations from RA data.</p>
              </div>
              </div>
            </div>
            <div data-accordion-item style="border-bottom: 1px solid var(--grey-200);">
              <button data-accordion-trigger aria-expanded="false" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">Can the platform model IBD risk with IL-17 inhibitors?</h3>
                <svg data-accordion-icon width="16" height="16" viewBox="0 0 16 16" fill="none" style="flex-shrink: 0;"><path d="M4 6l4 4 4-4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg>
              </button>
              <div data-accordion-content aria-hidden="true" style="max-height: 0; overflow: hidden; transition: max-height 300ms ease-out;">
                <div style="padding: 0 0 var(--space-5);">
                  <p class="arca-body-sm arca-text-grey-600">Yes. ArcaScience integrates clinical trial data from SPIRIT, MEASURE, and BE OPTIMAL programs with post-marketing surveillance databases to model new-onset and exacerbation of IBD events associated with IL-17 blockade. Our models identify patients at elevated IBD risk based on family history, subclinical gut inflammation biomarkers, and prior GI symptoms, enabling proactive risk stratification and supporting contraindication labeling decisions for secukinumab, ixekizumab, and bimekizumab.</p>
              </div>
              </div>
            </div>
            <div data-accordion-item style="border-bottom: 1px solid var(--grey-200);">
              <button data-accordion-trigger aria-expanded="false" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">How does ArcaScience support treatment sequencing BRA across mechanism classes?</h3>
                <svg data-accordion-icon width="16" height="16" viewBox="0 0 16 16" fill="none" style="flex-shrink: 0;"><path d="M4 6l4 4 4-4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg>
              </button>
              <div data-accordion-content aria-hidden="true" style="max-height: 0; overflow: hidden; transition: max-height 300ms ease-out;">
                <div style="padding: 0 0 var(--space-5);">
                  <p class="arca-body-sm arca-text-grey-600">PsA treatment algorithms often involve sequencing from TNF inhibitors to IL-17 inhibitors, IL-23 blockers, or JAK inhibitors after inadequate response. Our platform models cumulative safety exposure across sequential mechanism classes, predicting carry-over risks and washout-dependent adverse event patterns. This includes modeling the impact of prior TNF inhibitor exposure on subsequent IL-17 or JAK inhibitor safety profiles, enabling comprehensive benefit-risk evaluation for second- and third-line treatment positioning.</p>
              </div>
              </div>
            </div>
            <div data-accordion-item>
              <button data-accordion-trigger aria-expanded="false" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">Does the platform handle dual psoriasis-PsA BRA for biologics?</h3>
                <svg data-accordion-icon width="16" height="16" viewBox="0 0 16 16" fill="none" style="flex-shrink: 0;"><path d="M4 6l4 4 4-4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg>
              </button>
              <div data-accordion-content aria-hidden="true" style="max-height: 0; overflow: hidden; transition: max-height 300ms ease-out;">
                <div style="padding: 0 0 var(--space-5);">
                  <p class="arca-body-sm arca-text-grey-600">Absolutely. Many biologics approved for PsA also hold psoriasis indications, and up to 30% of psoriasis patients develop PsA. Our platform provides integrated benefit-risk analysis that spans both indications, linking dermatology trial data (PASI, IGA) with rheumatology endpoints (ACR, enthesitis resolution, dactylitis resolution). This dual-indication BRA supports unified labeling strategies, cross-indication safety signal detection, and regulatory submissions that address both dermatology and rheumatology review divisions simultaneously.</p>
              </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- CTA -->
    <section class="arca-cta-section" data-animate style="position: relative; overflow: hidden;">
      <div style="position: absolute; top: -60px; left: -60px; width: 300px; height: 300px; background: radial-gradient(circle, rgba(255,255,255,0.08) 0%, transparent 70%); border-radius: 50%; filter: blur(40px); pointer-events: none; animation: as-float 7s ease-in-out infinite; z-index: 0;"></div>
      <div style="position: absolute; bottom: -40px; right: -40px; width: 250px; height: 250px; background: radial-gradient(circle, rgba(255,255,255,0.06) 0%, transparent 70%); border-radius: 50%; filter: blur(40px); pointer-events: none; animation: as-float 9s ease-in-out infinite reverse; z-index: 0;"></div>
      <div style="position: relative; z-index: 1; max-width: 680px; margin: 0 auto; padding: 0 24px;">
        <h2 class="arca-heading-1" style="margin-bottom: var(--space-5);">See ArcaScience Applied to Psoriatic Arthritis</h2>
        <p class="arca-body-lg" style="margin-bottom: var(--space-7);">Request a demonstration focused on psoriatic arthritis BRA. Our immunology and rheumatology scientists will present JAK inhibitor cardiovascular risk models, multi-domain efficacy-safety analysis, and treatment sequencing BRA frameworks across all six approved mechanism classes.</p>
        <div style="display: flex; gap: 16px; justify-content: center; flex-wrap: wrap;">
          <a href="/contact?disease=psoriatic-arthritis" class="arca-btn-primary-inverted">Request PsA Briefing</a>
          <a href="/platform-overview" class="arca-btn-secondary" style="border-color: rgba(255,255,255,0.3); color: var(--white);">Explore the Platform <span class="arca-arrow">&rarr;</span></a>
        </div>
      </div>
    </section>

  </main>

    <!-- RELATED DISEASES -->
    <section class="arca-bg-grey-50" style="padding: var(--space-7) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-6);">
          <p class="arca-section-label">Explore More</p>
          <h2 class="arca-heading-2" style="margin-bottom: var(--space-3);">
            Related Dermatology Disease Pages
          </h2>
        </div>
        <div style="display: flex; flex-wrap: wrap; gap: 12px; justify-content: center;" data-animate-stagger>
          <a href="/ta-dermatology" class="arca-card" style="text-decoration: none; color: inherit; padding: var(--space-3) var(--space-5); text-align: center;" data-animate="slide-up">
            <span class="arca-heading-4" style="display: block; margin-bottom: 4px;">&larr; All Dermatology</span>
            <span class="arca-body-sm arca-text-grey-500">Back to overview</span>
          </a>
          <a href="/disease-atopic-dermatitis" class="arca-card" style="text-decoration: none; color: inherit; padding: var(--space-3) var(--space-5); text-align: center;" data-animate="slide-up">
            <span class="arca-heading-4" style="display: block; margin-bottom: 4px;">Atopic Dermatitis</span>
            <span class="arca-body-sm arca-text-grey-500">View BRA &rarr;</span>
          </a>
        </div>
      </div>
    </section>

  <!-- FOOTER -->
  <footer class="arca-bg-blue-900" style="padding: var(--space-9) 0 var(--space-7);">
    <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
      <div style="display: grid; grid-template-columns: 2fr 1fr 1fr 1fr 1fr; gap: 48px;">
        <div><img src="/images/arcascience-logo-white.svg" alt="ArcaScience" height="28" style="margin-bottom: var(--space-5);"><p class="arca-body-sm" style="color: rgba(255,255,255,0.65); max-width: 280px;">AI-driven benefit-risk analysis for pharmaceutical development. Founded 2018.</p></div>
        <div><p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Platform</p><nav style="display: flex; flex-direction: column; gap: 12px;"><a href="/platform-overview" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Overview</a><a href="/platform-data-intelligence" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Data Intelligence</a><a href="/platform-ai-models" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Decision Intelligence</a><a href="/platform-outputs" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Regulatory Outputs</a><a href="/security-compliance" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Security & Compliance</a></nav></div>
        <div><p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Solutions</p><nav style="display: flex; flex-direction: column; gap: 12px;"><a href="/solution-therapeutic-area" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Therapeutic Areas</a><a href="/ta-oncology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Oncology</a><a href="/ta-neurology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Neurology</a><a href="/ta-immunology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Immunology</a><a href="/ta-cardiology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Cardiology</a><a href="/ta-respiratory" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Respiratory</a><a href="/ta-rare-diseases" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Rare Diseases</a><a href="/ta-hematology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Hematology</a><a href="/ta-dermatology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Dermatology</a><a href="/solution-early-development" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Early Development</a><a href="/solution-late-development" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Late Development</a></nav></div>
        <div><p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Company</p><nav style="display: flex; flex-direction: column; gap: 12px;"><a href="/about" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">About</a><a href="/leadership" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Team</a><a href="/careers" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Careers</a><a href="/about" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">News</a><a href="/contact" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Contact</a></nav></div>
        <div><p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Resources</p><nav style="display: flex; flex-direction: column; gap: 12px;"><a href="/evidence-case-studies-hub" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Case Studies</a><a href="/resources-whitepapers" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Whitepapers</a><a href="/resources" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Blog</a><a href="/resources" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Documentation</a></nav></div>
      </div>
      <div style="margin-top: var(--space-8); padding-top: var(--space-5); border-top: 1px solid rgba(255,255,255,0.1); display: flex; justify-content: space-between; align-items: center;">
        <p class="arca-caption" style="color: rgba(255,255,255,0.45);">&copy; 2026 ArcaScience. All rights reserved.</p>
        <div style="display: flex; gap: 24px;">
          <a href="/legal-privacy" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Privacy</a>
          <a href="/legal-terms" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Terms</a>
          <a href="/legal-cookies" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Cookies</a>
          <a href="/legal-accessibility" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Accessibility</a>
        </div>
      </div>
    </div>
  </footer>

  <button data-back-to-top aria-label="Back to top"><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><path d="M8 12V4M4 7l4-4 4 4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round"/></svg></button>

  <script src="/dist/arcascience-global.min.js" defer></script>
  <script src="/dist/arcascience-countup.min.js" defer></script>
  <script>
    document.addEventListener('DOMContentLoaded', function() {
      if (window.ArcaScience) ArcaScience.init();
      if (window.ArcaScienceCountUp) ArcaScienceCountUp.init({ selector: '[data-countup]' });
    });
  </script>
</body>
</html>